Regencell Bioscience Holdings Ltd

RGC

Exchange: Nasdaq
Industry: Medicinal Chemicals & Botanical Products
SEC CIK: 0001829667

SEC filings (opens in a new tab)

No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Regencell Bioscience Holdings Ltd changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of RGC: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	4	3	−1
Shares	662	16.3K	+15.6K (+2,362.8%)
Value	$9.27K	$171.2K	+$161.9K (+1,746.4%)

New holders (1)

Institutions that held Regencell Bioscience Holdings Ltd at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to RGC in Q4 2023
Institution	Shares	Value	% of portfolio
UBS Group AG	16,053	$168.6K	0.00%

Sold out (2)

Institutions that held Regencell Bioscience Holdings Ltd at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of RGC in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Morgan Stanley	326	$4.56K
Tower Research Capital LLC (TRC)	85	$1.19K